Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 12th February 2021
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

NOAH welcomes VMD’s new Regulatory Science Strategy
NOAH called the evidence-based approach a positive step forward which will help to secure a future for development, authorisation and regulation of veterinary medicines in the UK.

New evidence-based approach will help bolster VMD's work.

The National Office of Animal Health Limited (NOAH) has shown support for the new Regulatory Science Strategy outlined by the Veterinary Medicines Directorate (VMD).

The Strategy Vision is: “To promote the scientific basis underlying the authorisation and regulation of veterinary medicines, ensuring the availability of products which support animal health whilst protecting public health and the environment.”

It aims to ensure that the VMD remains informed on future technological advances and new approaches, so that it can be prepares to address scientific and regulatory challenges that may arise.

In a statement NOAH praised this commitment to an evidence-based approach, calling it a positive step forward which will help secure a future for development, authorisation and regulation of veterinary medicines in the UK based on a rational and flexible regulatory platform.

NOAH chief executive Dawn Howard said: “We provided feedback on the objectives and strategic goals of the strategy followed by key points our sector consider to be important in the upcoming review of the Veterinary Medicines Regulations, an important instrument to support the VMD Regulatory Science Strategy.

“Execution of this strategy will be a long-term objective and we have stressed that it will be important that VMD continues to consult with stakeholders regularly and proactively. NOAH would welcome more dialogue on this in the future as plans evolve.’’

To view the draft Regulatory Science Strategy please click here.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.